Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.34 |
| ▸ | FDPS | P14324 | 7/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetostearyl Alcohol SCHEMBL28094787 | 0.78 | LMNA (0.59) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL6770068 | 0.76 | S1PR1 (0.43) | S1PR1EPHX2GGPS1FDPSFAAH | |
| SCHEMBL8205811 | 0.74 | GGPS1 (0.41) | S1PR1EPHX2GGPS1FDPSFAAH | |
| 1,4-Butanediol SCHEMBL575401 | 0.73 | SMN1; SMN2 (0.52) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Dodecane SCHEMBL28288842 | 0.73 | LMNA (0.50) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Decane SCHEMBL27812031 | 0.73 | LMNA (0.50) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Octane SCHEMBL1843443 | 0.73 | LMNA (0.50) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Tridecan-1-Ol SCHEMBL28721719 | 0.73 | LMNA (0.65) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Octanol SCHEMBL208036 | 0.73 | LMNA (0.72) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Sulfuric Acid SCHEMBL9563634 | 0.73 | LMNA (0.72) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | PUF60, PHOSPHO1, PLA2G2C | LMNA 2132/4885ALDH1A1 1763/4885HSD17B10 2058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.